Puravive is a weight loss supplement that has become a topic of discussion in the market over the last few weeks. This ...

A new weight loss pill called amycretin has helped people lose up to 13% of their body weight in just three months, according to a recent study presented at the annual meeting of the European ...

Kourtney Kardashian is hopping on the weight loss trend with the launch of her new Lemme GLP-1 Daily capsules. The “Kardashians” star, 45, announced what are some are already referring to as ...

Puravive's weight loss pill combines eight natural ingredients known to elevate brown adipose tissue levels. For instance, ingredients like luteolin, holy basil, and kudzu enhance BAT levels ...

An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo ...

Ozempic maker Novo Nordisk says its highly anticipated experimental weight-loss pill Amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects.

An experimental weight-loss pill is showing promising results, helping people drop 13% of their body weight in a three-month period. The results from early clinical trials were presented by Novo ...

In terms of efficacy, Roche reiterated its statement in July that the once-daily pill CT-996 resulted in a placebo-adjusted average weight loss of 6.1% within four weeks in obese patients without ...

The pill is made by Novo Nordisk, the same company that makes Ozempic. The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill. Novo Nordisk released ...

The phase 1 trials also show some mild and moderate side effects, primarily gastrointestinal, similar to those of other weight-loss drugs. The obesity pill could prove stiff competition for Eli ...

Roche's experimental weight-loss pill, CT-996, showed promising early-stage trial results, causing shares to rise. However, findings were based on just six patients in the most successful subgroup.